Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1450 of 1467 entries
View as:

SAMBA: Sexuality And Management of Benign Prostatic Hyperplasia With Alfuzosin

Phase: N/A Priority: Normal
NCT ID: NCT00486785 Org: User:
Start: 04/30/06 End: 03/31/08 Due: 03/31/09

Evaluation of Safety of Cabazitaxel (Jevtana) in Patients With Metastatic Hormone Refractory Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02074137 Org: User:
Start: 07/31/14 End: 03/31/16 Due: 03/31/17

Repeated Dosing Study to Assess Safety and Tolerability in CKD-3 Patients on Stable ACE-I Treatment

Phase: N/A Priority: Normal
NCT ID: NCT01485900 Org: User:
Start: 11/30/11 End: 08/31/12 Due: 08/31/13

Lantus Versus Humalog Mix as add-on Therapy in Type Diabetes Patients Failing Sulfonylurea and Metformin Combination Treatment

Phase: N/A Priority: Normal
NCT ID: NCT01336751 Org: User:
Start: 07/31/01 End: 12/31/02 Due: 12/31/03

Efficacy and Safety of Efpeglenatide Versus Placebo in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Alone or in Combination With Sulfonylurea

Phase: N/A Priority: Normal
NCT ID: NCT03770728 Org: User:
Start: 08/01/19 End: 12/27/20 Due: 12/27/21

A Study of SAR444245 With or Without Other Anticancer Therapies for the Treatment of Adults and Adolescents With Relapsed or Refractory B Cell Lymphoma (Master Protocol) [Pegathor Lymphoma 205]

Phase: N/A Priority: Normal
NCT ID: NCT05179603 Org: User:
Start: 12/07/21 End: 09/06/24 Due: 09/06/25

Safety and Quality of Life Study of Aflibercept in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen

Phase: N/A Priority: Normal
NCT ID: NCT01571284 Org: User:
Start: 05/30/12 End: 01/31/17 Due: 01/31/18

Efficacy & Safety of Dronedarone Versus Amiodarone for the Maintenance of Sinus Rhythm in Patients With Atrial Fibrillation

Phase: N/A Priority: Normal
NCT ID: NCT00489736 Org: User:
Start: 06/30/07 End: 10/31/08 Due: 10/31/09

Efficacy and Safety of SR58611 Compared to Placebo and Paroxetine

Phase: N/A Priority: Normal
NCT ID: NCT00825058 Org: User:
Start: 11/30/03 End: 10/31/04 Due: 10/31/05

A Phase 2 Trial of Standard Chemotherapy, With or Without BSI-201, in Patients With Triple Negative Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00540358 Org: User:
Start: 10/31/07 End: 06/30/10 Due: 06/30/11

A Clinical Study to Investigate if SAR425899 Binds to the Liver and Pancreas in Overweight to Obese Type 2 Diabetes Mellitus Patients

Phase: N/A Priority: Normal
NCT ID: NCT03350191 Org: User:
Start: 12/20/17 End: 06/07/18 Due: 06/07/19

An Eight-Week Study Evaluating the Efficacy and Tolerability of Two Doses of SSR149415 in Outpatients With Major Depressive Disorder

Phase: N/A Priority: Normal
NCT ID: NCT00358631 Org: User:
Start: 07/31/06 End: 12/31/07 Due: 12/31/08

Long Term Safety and Efficacy of Teriflunomide (HMR1726) in Multiple Sclerosis With Relapses

Phase: N/A Priority: Normal
NCT ID: NCT00228163 Org: User:
Start: 01/31/02 End: 01/31/15 Due: 01/31/16

TELI TAD - Telithromycin in Tonsillitis in Adolescents and Adults

Phase: N/A Priority: Normal
NCT ID: NCT00315549 Org: User:
Start: 02/28/06 End: 09/30/06 Due: 09/30/07

A Study of AVE8062 in Advanced-stage Soft Tissue Sarcoma After Failure of Anthracycline and Ifosfamide Chemotherapies

Phase: N/A Priority: Normal
NCT ID: NCT00699517 Org: User:
Start: 06/30/08 End: 04/30/13 Due: 04/30/14

Irbesartan/Amlodipine in Hypertensive Patients Uncontrolled on Irbesartan 150 mg Monotherapy

Phase: N/A Priority: Normal
NCT ID: NCT00957554 Org: User:
Start: 07/31/09 End: 09/30/10 Due: 09/30/11

Study of Safety and Effectiveness of Apidra® in Combination With Basal Insulin in Patients With Type 1 & 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT00526513 Org: User:
Start: 07/31/07 End: 05/31/08 Due: 05/31/09

A Study to Evaluate the Treatment Response and Safety of Two Dose Regimens of Subcutaneous Amlitelimab Compared With Treatment Withdrawal in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis

Phase: N/A Priority: Normal
NCT ID: NCT06407934 Org: User:
Start: 05/08/24 End: 04/05/27 Due: 04/05/28

TEACO: Taxotere, Eloxatin, Avastin in Cancer of the Ovary

Phase: N/A Priority: Normal
NCT ID: NCT00296816 Org: User:
Start: 03/31/06 End: 08/31/11 Due: 08/31/12

Study Combining SAR245409 With Rituximab or Bendamustine Plus Rituximab in Patients With Indolent Lymphoma, Mantle Cell Lymphoma and Chronic Lymphocytic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT01410513 Org: User:
Start: 12/31/11 End: 05/31/14 Due: 05/31/15

A Study to Assess the Safety of Myozyme® and of Aldurazyme® in Male and Female Participants of Any Age Group With Pompe Disease or With Mucopolysaccharidosis Type I (MPS I) in a Home-care Setting

Phase: N/A Priority: Normal
NCT ID: NCT05073783 Org: User:
Start: 10/14/21 End: 01/31/24 Due: 01/31/25

Colorectal Cancer Metastatic

Phase: N/A Priority: Normal
NCT ID: NCT01670721 Org: User:
Start: 08/31/12 End: 06/30/15 Due: 06/30/16

Phase III Study With Teriflunomide Versus Placebo in Patients With First Clinical Symptom of Multiple Sclerosis

Phase: N/A Priority: Normal
NCT ID: NCT00622700 Org: User:
Start: 02/29/08 End: 02/29/16 Due: 02/28/17

Investigate the Maximum Tolerated Dose of Vandetanib and Concurrent Whole Brain Radiotherapy (WBRT) in Patients With Non-small Cell Lung Cancer (NSCLC) and Brain Metastases

Phase: N/A Priority: Normal
NCT ID: NCT00807170 Org: User:
Start: 05/31/09 End: 08/31/10 Due: 08/31/11

A Study to Investigate Safety and Efficacy of iGlarLixi in Adult Patients With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT06716424 Org: User:
Start: 01/06/25 End: 07/21/25 Due: 07/21/26